RYOJBABA CO LTD (RYOJ) Stock Fundamental Analysis
NASDAQ:RYOJ • JP3976100002
2.6 USD
-0.19 (-6.81%)
At close: Feb 11, 2026
2.55 USD
-0.05 (-1.92%)
Pre-Market: 2/12/2026, 7:00:00 AM
We assign a fundamental rating of 3 out of 10 to RYOJ. RYOJ was compared to 102 industry peers in the Health Care Providers & Services industry. RYOJ has an average financial health and profitability rating. RYOJ has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- RYOJ had positive earnings in the past year.
- In the past year RYOJ had a positive cash flow from operations.
1.2 Ratios
- With an excellent Return On Assets value of 10.78%, RYOJ belongs to the best of the industry, outperforming 94.12% of the companies in the same industry.
- RYOJ has a better Return On Equity (68.65%) than 97.06% of its industry peers.
- RYOJ has a Return On Invested Capital of 13.27%. This is amongst the best in the industry. RYOJ outperforms 90.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.78% | ||
| ROE | 68.65% | ||
| ROIC | 13.27% |
ROA(3y)3.47%
ROA(5y)N/A
ROE(3y)13.47%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- RYOJ's Profit Margin of 10.32% is amongst the best of the industry. RYOJ outperforms 94.12% of its industry peers.
- RYOJ's Operating Margin of 14.65% is amongst the best of the industry. RYOJ outperforms 88.24% of its industry peers.
- The Gross Margin of RYOJ (38.12%) is better than 68.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.65% | ||
| PM (TTM) | 10.32% | ||
| GM | 38.12% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- RYOJ has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for RYOJ remains at a similar level compared to 1 year ago.
- RYOJ has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 3.13 indicates that RYOJ is not in any danger for bankruptcy at the moment.
- The Altman-Z score of RYOJ (3.13) is better than 67.65% of its industry peers.
- The Debt to FCF ratio of RYOJ is 7.55, which is on the high side as it means it would take RYOJ, 7.55 years of fcf income to pay off all of its debts.
- With a Debt to FCF ratio value of 7.55, RYOJ perfoms like the industry average, outperforming 57.84% of the companies in the same industry.
- RYOJ has a Debt/Equity ratio of 1.52. This is a high value indicating a heavy dependency on external financing.
- RYOJ has a Debt to Equity ratio of 1.52. This is in the lower half of the industry: RYOJ underperforms 68.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.52 | ||
| Debt/FCF | 7.55 | ||
| Altman-Z | 3.13 |
ROIC/WACC2.17
WACC6.12%
2.3 Liquidity
- A Current Ratio of 1.42 indicates that RYOJ should not have too much problems paying its short term obligations.
- RYOJ has a Current ratio of 1.42. This is comparable to the rest of the industry: RYOJ outperforms 53.92% of its industry peers.
- A Quick Ratio of 1.40 indicates that RYOJ should not have too much problems paying its short term obligations.
- RYOJ has a Quick ratio (1.40) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.42 | ||
| Quick Ratio | 1.4 |
3. Growth
3.1 Past
- RYOJ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.07%, which is quite impressive.
- RYOJ shows a small growth in Revenue. In the last year, the Revenue has grown by 3.47%.
EPS 1Y (TTM)52.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.86%
Revenue 1Y (TTM)3.47%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.03%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 16.25, which indicates a correct valuation of RYOJ.
- RYOJ's Price/Earnings ratio is rather cheap when compared to the industry. RYOJ is cheaper than 82.35% of the companies in the same industry.
- RYOJ is valuated rather cheaply when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.25 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, RYOJ is valued a bit cheaper than 71.57% of the companies in the same industry.
- RYOJ's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 42.94 | ||
| EV/EBITDA | 10.86 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- RYOJ does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
2.6
-0.19 (-6.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.52%
Inst Owner Change-77.91%
Ins Owners51.51%
Ins Owner ChangeN/A
Market Cap29.25M
Revenue(TTM)16.72M
Net Income(TTM)1.73M
AnalystsN/A
Price TargetN/A
Short Float %0.68%
Short Ratio0.42
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.25 | ||
| Fwd PE | N/A | ||
| P/S | 1.74 | ||
| P/FCF | 42.94 | ||
| P/OCF | 36.45 | ||
| P/B | 11.6 | ||
| P/tB | 33.81 | ||
| EV/EBITDA | 10.86 |
EPS(TTM)0.16
EY6.15%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.06
FCFY2.33%
OCF(TTM)0.07
OCFY2.74%
SpS1.49
BVpS0.22
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.9
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.78% | ||
| ROE | 68.65% | ||
| ROCE | 21.39% | ||
| ROIC | 13.27% | ||
| ROICexc | 17.17% | ||
| ROICexgc | 21.1% | ||
| OM | 14.65% | ||
| PM (TTM) | 10.32% | ||
| GM | 38.12% | ||
| FCFM | 4.06% |
ROA(3y)3.47%
ROA(5y)N/A
ROE(3y)13.47%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.52 | ||
| Debt/FCF | 7.55 | ||
| Debt/EBITDA | 1.31 | ||
| Cap/Depr | 25.83% | ||
| Cap/Sales | 0.72% | ||
| Interest Coverage | 31.8 | ||
| Cash Conversion | 27.41% | ||
| Profit Quality | 39.36% | ||
| Current Ratio | 1.42 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 3.13 |
F-Score7
WACC6.12%
ROIC/WACC2.17
Cap/Depr(3y)211.5%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.46%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.47%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y42.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y147.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y106.27%
OCF growth 3YN/A
OCF growth 5YN/A
RYOJBABA CO LTD / RYOJ FAQ
What is the fundamental rating for RYOJ stock?
ChartMill assigns a fundamental rating of 3 / 10 to RYOJ.
What is the valuation status of RYOJBABA CO LTD (RYOJ) stock?
ChartMill assigns a valuation rating of 3 / 10 to RYOJBABA CO LTD (RYOJ). This can be considered as Overvalued.
How profitable is RYOJBABA CO LTD (RYOJ) stock?
RYOJBABA CO LTD (RYOJ) has a profitability rating of 5 / 10.
What is the valuation of RYOJBABA CO LTD based on its PE and PB ratios?
The Price/Earnings (PE) ratio for RYOJBABA CO LTD (RYOJ) is 16.25 and the Price/Book (PB) ratio is 11.6.
Can you provide the financial health for RYOJ stock?
The financial health rating of RYOJBABA CO LTD (RYOJ) is 4 / 10.